UK government urged to offer meningitis B vaccine to teenagers on NHS
Translated from English, summarized and contextualized by DistantNews.
At a glance
- Government advisers recommended offering teenagers a meningitis B vaccine on the NHS.
- The Joint Committee on Vaccination and Immunisation (JCVI) suggests children receive the jab around age 15.
- The recommendation requires government approval and may include catch-up programs for eligible individuals.
Advisers to the UK government have recommended offering teenagers a vaccine against the deadly meningitis B (menB) disease on the National Health Service (NHS). The Joint Committee on Vaccination and Immunisation (JCVI) proposed that young people should receive one or two doses of the menB vaccine around the age of 15. This recommendation, which needs government approval, also suggests implementing catch-up programs for those who might otherwise miss out on the vaccination.
Meningitis B is a serious infection that can cause severe illness, disability, and death. While a menB vaccine is already part of the routine childhood immunization schedule, the JCVI's new advice aims to extend protection to older children and adolescents who may not have received it at a younger age. The committee's proposal reflects ongoing efforts to reduce the incidence of this potentially devastating disease.
Details regarding the specific number of doses and the exact age for catch-up programs will be determined once the government reviews the JCVI's recommendation. The decision to implement the vaccine on the NHS will be a significant public health step, potentially preventing numerous cases of meningitis B among teenagers in the United Kingdom.
Originally published by The Guardian in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.